Sapio’s no-code platform will assist genomic sequencing tasks carried out in Genseq’s CAP-accredited sequencing laboratory.
Picture Credit score: Owlie Productions/Shutterstock.com
Genseq, a Dublin-based, CAP-accredited laboratory offering a variety of providers for biopharma and medical analysis, has adopted the science-aware™ lab informatics platform from Sapio Sciences to handle its next-generation sequencing (NGS) and biobanking workflows. Genseq intends to deploy Sapio’s LIMS (Laboratory Data Administration System) performance to automate important knowledge trade between devices and laboratory techniques, observe pattern data from receipt by sequencing, and assess key efficiency indicators and high quality management.
Based in 2023, Genseq makes use of state-of-the-art sequencing platforms, together with Novaseq, Nextseq, and Nextseq Dx, to make sure glorious high quality and accuracy in sequencing knowledge technology. Along with offering a full vary of genomics, transcriptomics, and single-cell sequencing providers, Genseq’s biobanking facility can accommodate greater than 500,000 samples.
Genseq will use the superior LIMS performance from Sapio to trace all points of pattern administration, together with pattern accessioning, storage, high quality management, and aliquoting. Genseq will use Sapio’s built-in hCRM (Healthcare Buyer Relationship Administration) to obtain and course of orders by their web site and enhance communication with purchasers for numerous laboratory providers, together with biopharma and medical analysis. Along with aiding Genseq’s scientists in managing the various duties related to sequencing, the LIMS will assist lab managers collect key metrics about lab processes and help high quality managers in assessing key efficiency indicators for purchasers whereas additionally offering key knowledge to assist in bettering Genseq’s inside processes.
“As a result of we offer cutting-edge sequencing providers, it was essential to us to discover a fashionable LIMS that would assist our workflows finish to finish with out requiring in depth and time-consuming customization,” stated Patrick Buckley, Chief Scientific Officer, at Genseq. “The Sapio platform allows us to hold out constant, reproducible work and automates key duties in order that our scientists can deal with delivering the very best outcomes attainable to our purchasers as rapidly as attainable.”
The Sapio platform unifies LIMS, digital laboratory pocket book (ELN), and scientific knowledge administration performance in a single cloud system. The corporate not too long ago introduced the inclusion of AI capabilities in its ELN (ELaiN), together with full GxP validation of its platform.
“We’re at all times proud to assist revolutionary organizations in pushing the boundaries of science and delivering important providers to stoke the subsequent technology of biopharma breakthroughs,” stated Kevin Cramer, president and CEO of Sapio Sciences. “Sapio is supporting Genseq in assembly its promise to purchasers, and we’re excited to companion with them as they develop their capabilities to satisfy demand.”
About Genseq
Genseq gives a genomic/multi-omic sequencing service to Academia, Biopharma and CROs. Present service consists of knowledge technology, bioinformatics, and knowledge evaluation, delivers numerous knowledge sorts, similar to Entire Genome Sequencing, Entire Exome Sequencing, Sanger Sequencing, RNA Sequencing, Single Cell/Nuclei Sequencing, Methylation Profiling and Genotyping
About Sapio Sciences
Sapio Sciences’ mission is to enhance lives by accelerating discovery, and since science is advanced, Sapio makes know-how easy. Sapio is a worldwide enterprise providing an all-in-one science-awareTM lab informatics platform combining cloud-based LIMS, ELN, and Jarvis knowledge options. Sapio serves a few of the largest international and area of interest manufacturers, together with biopharma, CROs and medical diagnostic labs throughout NGS genomic sequencing, bioanalysis, bioprocessing, stability, medical, histopathology, drug analysis, and in vivo research. Prospects love Sapio’s platform as a result of it’s strong, scalable, and with no-code configuration, can rapidly adapt to satisfy distinctive wants. For extra data, go to www.sapiosciences.com and comply with us on LinkedIn.
